BMI1 and breast carcinoma: Currently, knockdown of miR-128 in breast tumor-initiating cells was reported to induce chemotherapeutic resistance, which contributes to chemotherapeutic resistance in breast cancers by targeting of Bmi-1 and ATP binding cassette subfamily C member 5 (ABCC5) [34].